The major goal of this proposal is to gain a molecular understanding of the mechanism of signal transduction by calcineurin during activation of T lymphocytes. The investigator has identified calcineurin as an important enzyme in the T cell receptor (TCR)-mediated signal transduction pathway leading to interleukin-2 (IL-2) production and as a common target for the immunosuppressive drugs cyclosporin A and FK506. Calcineurin is known to modulate the activities of at least three distinct classes of transcription factor including NF-AT, NF-kB and AP-1. However, many of the signaling molecules involved in the activation of NF-kB and AP-1 by calcineurin are not known. Calcineurin exists in multiple isoforms; it has been assumed that the a isoform of calcineurin mediates TCR signaling. Recently, calcineurin a was knocked out in mice, but no defect in the TCR-mediated IL-2 production was observed. In his preliminary studies, he has found that another isoform, calcineurin b, is more abundant than calcineurin a in T cells, suggesting that calcineurin b may play a dominant role in TCR signaling. Using FK506-resistant calcineurin mutants, he proposes to assess whether calcineurin b is sufficient to mediate TCR signaling. He will apply the yeast two-hybrid system to identify the substrates and associated proteins for calcineurin b to uncover signaling molecules involved in the activation of NF-kB and AP-1 by calcineurin. Alternatively, he will also employ catalytically inactive calcineurin mutants to identify calcineurin substrates from Jurkat cell extracts in vitro. Using partial cDNA sequences obtained from the yeast two-hybrid screen or oligopeptide sequences obtained from in vitro binding, the full length cDNA encoding putative calcineurin substrates and associated proteins will be cloned and further characterized in the context of TCR signaling. The identification of new signaling molecules through these studies will not only shed light on the molecular mechanism of TR signal transduction, but will also offer new targets for designing more specific and less toxic immunosuppressants.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM055783-06S1
Application #
6697994
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Marino, Pamela
Project Start
1997-05-01
Project End
2004-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
6
Fiscal Year
2003
Total Cost
$58,860
Indirect Cost
Name
Johns Hopkins University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Liu, Jun O (2009) Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation. Immunol Rev 228:184-98
Romo, Daniel; Choi, Nam Song; Li, Shukun et al. (2004) Evidence for separate binding and scaffolding domains in the immunosuppressive and antitumor marine natural product, pateamine a: design, synthesis, and activity studies leading to a potent simplified derivative. J Am Chem Soc 126:10582-8
Pan, Fan; Ye, Zhaohui; Cheng, Linzhao et al. (2004) Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). J Biol Chem 279:14477-80
Huai, Qing; Kim, Hwa-Young; Liu, Yudong et al. (2002) Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci U S A 99:12037-42
Smulik, Jason A; Diver, Steven T; Pan, Fan et al. (2002) Synthesis of cyclosporin A-derived affinity reagents by olefin metathesis. Org Lett 4:2051-4
Esau, C; Boes, M; Youn, H D et al. (2001) Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells. J Exp Med 194:1449-59
Liu, W; Youn, H D; Zhou, X Z et al. (2001) Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS Lett 496:105-8
Youn, H D; Grozinger, C M; Liu, J O (2000) Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J Biol Chem 275:22563-7
Youn, H D; Liu, J O (2000) Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13:85-94
Youn, H D; Sun, L; Prywes, R et al. (1999) Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 286:790-3